| Negative n (%) | bla KPC n (%) | bla VIM n (%) | bla IMP n (%) | bla OXA−48−like n (%) | bla NDM n (%) | Total n (%) |
---|---|---|---|---|---|---|---|
Gender | Â | Â | Â | Â | Â | Â | Â |
Male | 34 (66.7) | 13 (25.5) | 2 (3.9) | 1 (2.0) | 1 (2.0) | 0 (0.0) | 51 (51.0) |
Female | 43 (87.8) | 5 (10.2) | 1 (2.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 49 (49.0) |
Referral type (%), | Â | Â | Â | Â | Â | Â | Â |
Inpatient | 56 (80.0) | 10 (14.3) | 3 (4.3) | 1 (1.4) | 0 (0.0) | 0 (0.0) | 70 (70.0) |
Outpatient | 21 (70.0) | 8 (26.7) | 0 (0.0) | 0 (0.0) | 1 (3.3) | 0 (0.0) | 30 (30.0) |
Sample type (%), | Â | Â | Â | Â | Â | Â | Â |
Urine | 44 (77.2) | 10 (17.5) | 2 (3.5) | 1 (1.8) | 0 (0.0) | 0 (0.0) | 57 (57.0) |
Blood | 20 (74.1) | 5 (18.5) | 1 (3.7) | 0 (0.0) | 1 (3.7) | 0 (0.0) | 27 (27.0) |
Wound | 10 (76.9) | 3 (23.1) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 13 (13.0) |
Sputum | 3 (100.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 3 (3.0) |
Total | 77 (77.0) | 18 (18.0) | 3 (3.0) | 1 (1.0) | 1 (1.0) | 0 (0.0) | 100 (100.0) |